ISIN
CY0109800710
Ticker
IDNA
Sector
Sub-Industry
Country
Cyprus
Year Founded
2020
Our company operates in the booming industry of Precision Medicine and Genetic Analysis. Our focus is on developing and providing genetic analysis for Pharmacogenetics. Preventive Medicine and Genomics of Nutrition and Sports, with constant research activity through co-operation with universities in Greece and abroad.
We specialise in Genetics and fully exploit cutting-edge scientific knowledge, to provide innovative DNA analysis services that allow everybody to access their unique genetic traits, with a personalised approach.
We develop innovative and pioneering solutions by leveraging our multidimensional expertise, our scientific staff and Research & Development (R&D) department, the certified laboratories and privately owned bioinformatics analysis platform, a state-of-the-art technology and the collaboration with prestigious Universities and Research Organisations.
Cyprus
CY0109800710
2549006HMJWPY9CIB812
CSE General Index
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.